rs757350052
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001329943.3(KIAA0586):c.1254-1G>C variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,564,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001329943.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Joubert syndrome 23Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short-rib thoracic dysplasia 14 with polydactylyInheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndrome with Jeune asphyxiating thoracic dystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KIAA0586 | NM_001329943.3 | c.1254-1G>C | splice_acceptor_variant, intron_variant | Intron 9 of 30 | ENST00000652326.2 | NP_001316872.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KIAA0586 | ENST00000652326.2 | c.1254-1G>C | splice_acceptor_variant, intron_variant | Intron 9 of 30 | NM_001329943.3 | ENSP00000498929.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152158Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000682 AC: 15AN: 219932 AF XY: 0.0000844 show subpopulations
GnomAD4 exome AF: 0.000118 AC: 166AN: 1412474Hom.: 0 Cov.: 26 AF XY: 0.0000953 AC XY: 67AN XY: 702998 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74332 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Joubert syndrome 23 Pathogenic:5
A heterozygous canonical splice site variant was identified, NM_001244189.1(KIAA0586):c.1413-1G>C in intron 11 of the KIAA0586 gene. RNA studies have shown this substitution causes a frameshift from amino acid position 472 introducing a stop codon 2 residues downstream, NP_001231118.1(KIAA0586):p.(Arg472Serfs*2) resulting in loss of normal protein function through nonsense-mediated decay (NMD). The nucleotide at this position has low conservation (Phylop UCSC). In silico software predicts the splice site variant to cause aberrant splicing (NetGene2, Fruit fly, Human Splicing Finder). The variant is present in the gnomAD population database at a frequency of 0.0068% (15 heterozygotes, 0 homozygotes). It has been previously reported in patients with Joubert syndrome (ClinVar; Decipher; Roosing, S. et al., 2015; Bachmann-Gagescu, R. et al., 2015; Malicdan, M.C. et al., 2015). The variant has also been previously reported pathogenic in trans with p.(Arg309Ser) in a patient with Duane anomaly, macrocephaly, global developmental delay and molar tooth sign (Decipher). It has also been shown to segregate with the disease in one family (Roosing, S. et al., 2015). Based on information available at the time of curation, this variant has been classified as PATHOGENIC. -
ACMG codes:PVS1, PM2, PM3, PP5 -
- -
- -
- -
not provided Pathogenic:2
Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate that this variant leads to utilization of a cryptic splice acceptor site, resulting in an aberrant transcript and absent protein levels in patient fibroblasts (Roosing et al., 2015); This variant is associated with the following publications: (PMID: 26437029, 26026149, 26096313, 28497568, 30120217, 26386044, 27535533) -
- -
Joubert syndrome 23;C4225286:Short-rib thoracic dysplasia 14 with polydactyly Pathogenic:1
This sequence change affects an acceptor splice site in intron 11 of the KIAA0586 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. This variant is present in population databases (rs757350052, gnomAD 0.02%). Disruption of this splice site has been observed in individual(s) with Joubert syndrome (PMID: 26026149, 26096313, 26386044, 26437029, 28497568). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.1209-1G>C or c.1254-1G>C. ClinVar contains an entry for this variant (Variation ID: 204594). Studies have shown that disruption of this splice site results in activation of a cryptic splice site, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 26026149). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at